increased glutathione in acute myeloid leukemia ABCC1 and metabolism limit the efficacy of BCL-2 inhibitors Contribution of metabolic abnormalities to
Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis: Trends in Cell Biology Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia ScienceDirect Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia Current Treatment Options in Oncology Springer Nature Link Metabolic Plasticity of Acute Myeloid Leukemia
Pay in 4 interest-free payments of $6.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



